Gosset Ownership
Private
Employees
~18
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Edmond Pharma General Information
Edmond Pharma manufactures a wide range of generic APIs and finished dosage forms for human and veterinary use. The company has developed proprietary products such as Erdosteine, which is marketed in 40 countries worldwide and has received orphan drug status from the FDA. The company’s manufacturing site is authorized by major health authorities including AIFA, FDA, KFDA, and PMDA. Pipeline programs include Derpanicate for hyperlipidemia (discontinued) and Fenclozine Maleate for fever (pending).
Drug Pipeline
erdosteine
CommercialKey Partnerships
Not specified; as a CDMO/API supplier likely partners with multiple pharma companies globally
Edmond Pharma Funding
No funding data available
To view Edmond Pharma's complete valuation and funding history, request access »